DUSP22-deficient animal models exhibit risks of autoimmunity, and downregulation of DUSP22 in patients exhibits a strong relationship with systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD) [19,23,24]. Here, DUSP22 is linked to inflammatory bowel disease.